Search clinical trials for: recombinant luteinizing hormone (Luveris)

Total 339 results

Rigshospitalet, Denmark
Odense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaborators

Completed

Nordic Luveris Study

Infertility | In Vitro Fertilization

Denmark
EMD Serono

Completed

A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies

Infertility | Ovarian Stimulation
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Terminated

A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age

Infertility | Ovulation Induction

Spain
Merck KGaA, Darmstadt, Germany

Completed

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

Infertility | Ovulation Induction

Spain
EMD Serono

Terminated

Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

Hypogonadotropic Hypogonadism

United States
Assuta Hospital Systems
Maccabi Healthcare Services, Israel

Completed

Severe LH Suppressed Patients After Administration of a GnRH Antagonist (OPTOMALH)

Infertility, Female Infertility, Male Infertility

Israel
Royan Institute

Unknown

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

Infertility

Iran, Islamic Republic of
Merck KGaA, Darmstadt, Germany
Merck Pte. Ltd., Singapore

Completed

A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

Hypogonadism

China
Regionshospitalet Viborg, Skive

Completed

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Infertility | Controlled Ovarian Stimulation

Denmark
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Terminated

Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle (Luveris in ART)

Reproductive Techniques, Assisted

Italy
Peking University People's Hospital
Peking University First Hospital; The Second Hospital of Hebei Medical University and other collaborators

Unknown

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

Infertility, Female
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

Ovarian Stimulation

Spain
National Center for Research Resources (NCRR)
University of Texas

Completed

Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks

Porphyria

United States
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

Pergoveris FD and Liquid China BE Study

Healthy

China
Reproductive Medicine Associates of New Jersey

Completed

Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)

Outcome During r-hFSH Stimulation | Outcome During r-hFSH and r-hLH Stimulation

United States
Zhujiang Hospital

Recruiting

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases

Prostate Cancer With ≤10 Bone Metastases

China
Lawson Health Research Institute

Terminated

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer (FASTR)

Prostate Cancer

Canada
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Terminated

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

Infertility | Ovulation Induction

Spain
Columbia University
Tercica

Terminated

Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors

Growth Hormone Deficiency

United States
Ache Laboratorios Farmaceuticos S.A.

Unknown

Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects

Healthy Subjects

Brazil
NRG Oncology
National Cancer Institute (NCI)

Suspended

Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer (NADIR)

Prostate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

Canada, United States
Tianjin Medical University Cancer Institute and...
Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer (CRYO-PCA-IV)

Stage IV Prostate Cancer

China
Institut Cancerologie de l'Ouest
Astellas Pharma Inc; Direction Générale de l'Offre de Soins

Active, not recruiting

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients (OLIGOPELVIS2)

Prostate Cancer | Oligometastasis

France
University of Sydney
Memorial Sloan Kettering Cancer Center; Bayer; Canadian Cancer Trials Group; Australian... and other collaborators

Active, not recruiting

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

Prostate Cancer

United States, Canada, Australia, United Kingdom, New Zealand, Ireland
Rabin Medical Center
Ferring Pharmaceuticals

Completed

Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists

Cardiovascular Diseases | Prostatic Neoplasms

Israel
Assiut University

Unknown

Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital

β-Thalassemia Major Patients Receiving Chelation Therapy
University of Saskatchewan
Royal University Hospital Foundation

Completed

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

Infertility

Canada
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
University of Pisa

Completed

Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

Type 2 Diabetes | Metabolic Control

Italy
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Reproductive Hormonal Alterations in Obesity

Obesity

United States
University of British Columbia

Unknown

Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

Prostate Cancer

Canada
US Department of Veterans Affairs

Completed

Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.

Hypogonadism | Spinal Cord Injury

United States
Genuine Research Center, Egypt
Hikma Pharmaceuticals LLC

Completed

Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

Healthy

Egypt
Cinnagen

Completed

Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency

Idiopathic Growth Hormone Deficiency
Massachusetts General Hospital
Genentech, Inc.

Completed

Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

Anorexia Nervosa | Osteoporosis | Osteopenia | Eating Disorders

United States
Manuel Luque Ramírez
Instituto de Salud Carlos III

Completed

Phlebotomy and Polycystic Ovary Syndrome

Hyperandrogenism | Metabolic Cardiovascular Syndrome

Spain
Instituto Bernabeu

Unknown

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON)

Reproductive Techniques, Assisted

Spain
GeneScience Pharmaceuticals Co., Ltd.
Tongji Hospital; Shengjing Hospital; Shandong Provincial Hospital; Children's Hospital... and other collaborators

Recruiting

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

Achondroplasia

China
Weill Medical College of Cornell University
Genentech, Inc.

Suspended

Effect of Cytokines on Growth of Children With Chronic Kidney Failure

Chronic Renal Insufficiency

United States
Hamilton Health Sciences Corporation

Completed

Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

Heart Failure

Canada
National Center for Research Resources (NCRR)
Genentech, Inc.

Completed

Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

Cystic Fibrosis

United States
University of Maryland, Baltimore
Children's Hospital of Philadelphia

Withdrawn

Growth Hormone for Osteoporosis Pseudoglioma Syndrome (GHOPPG)

Osteoporosis Pseudoglioma Syndrome

United States
University Hospital Tuebingen

Completed

D3-GHR Polymorphism and Turner Syndrome

Turner Syndrome | Short Stature

Germany
Weill Medical College of Cornell University
Genentech, Inc.

Terminated

Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease

Chronic Kidney Disease

United States
Göteborg University
Pfizer

Completed

Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus (GHDM)

Obesity | Metabolic Syndrome | Abdominal Obesity

Sweden
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Healthy

United States
Sheba Medical Center

Unknown

Androgenic Profile Following Controlled Ovarian Stimulation

Infertility, Female
ClinAmygate

Withdrawn

Growth Hormone in Obese Cases With Covid-19

Covid19

Egypt
Nanjing First Hospital, Nanjing Medical University

Recruiting

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Radiotherapy; Complications | DTC - Differentiated Thyroid Cancer | Thyroid Stimulating; Hormone, C

China

Search clinical trials for: recombinant luteinizing hormone (Luveris)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations